SPONSOR
Jazz Pharmaceuticals
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
Conditions studied: Metastatic HER2-positive Breast CancerBreast CancerGastric CancerEsophageal CancerGastroesophageal CancerColorectal CancerEndometrial CancerNon-small Cell Lung CancerOvarian CancerUrothelial Carcinoma
Jazz Pharmaceuticals is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Metastatic HER2-positive Breast Cancer, Breast Cancer, Gastric Cancer, Esophageal Cancer.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jazz Pharmaceuticals
How many clinical trials has Jazz Pharmaceuticals sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Jazz Pharmaceuticals, of which 2 are actively recruiting participants. These trials cover conditions including Metastatic HER2-positive Breast Cancer, Breast Cancer, Gastric Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jazz Pharmaceuticals research focus on?
Jazz Pharmaceuticals clinical trials span Metastatic HER2-positive Breast Cancer, Breast Cancer, Gastric Cancer, Esophageal Cancer, Gastroesophageal Cancer, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jazz Pharmaceuticals clinical trial?
To participate in a Jazz Pharmaceuticals trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jazz Pharmaceuticals trials with current recruitment status updated daily.
Clinical Trials by Jazz Pharmaceuticals
NCT06435429 Phase 3
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Metastatic HER2-positive Breast Cancer
NCT06695845 Phase 2
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology